Nymox Pharmaceutical
NYMX
#10715
Rank
โ‚ฌ15.77 M
Marketcap
Country
0,17ย โ‚ฌ
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Nymox Pharmaceutical (NYMX)

Earnings in 2023 (TTM): -โ‚ฌ2.12 Million

According to Nymox Pharmaceutical's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -โ‚ฌ5.64 Million, an increase over its 2021 earnings that were of -โ‚ฌ10.79 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nymox Pharmaceutical from 1997 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -โ‚ฌ2.12 Million-62.52%
2022 -โ‚ฌ5.64 Million-47.71%
2021 -โ‚ฌ10.79 Million6.61%
2020 -โ‚ฌ10.12 Million-10.91%
2019 -โ‚ฌ11.36 Million24.24%
2018 -โ‚ฌ9.14 Million-20.03%
2017 -โ‚ฌ11.43 Million2.71%
2016 -โ‚ฌ11.13 Million-63.86%
2015 -โ‚ฌ30.79 Million674.44%
2014 -โ‚ฌ3.98 Million-6.11%
2013 -โ‚ฌ4.24 Million-35.66%
2012 -โ‚ฌ6.59 Million-20.76%
2011 -โ‚ฌ8.31 Million38.33%
2010 -โ‚ฌ6.01 Million35.59%
2009 -โ‚ฌ4.43 Million11.8%
2008 -โ‚ฌ3.97 Million-12.94%
2007 -โ‚ฌ4.55 Million8.85%
2006 -โ‚ฌ4.18 Million36.5%
2005 -โ‚ฌ3.07 Million-4.4%
2004 -โ‚ฌ3.21 Million-14.58%
2003 -โ‚ฌ3.76 Million
2001 -โ‚ฌ2.76 Million-20.54%
2000 -โ‚ฌ3.47 Million21.72%
1999 -โ‚ฌ2.85 Million-25.56%
1998 -โ‚ฌ3.83 Million101.3%
1997 -โ‚ฌ1.9 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ22.44 B-1,202,274.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ9.15 B-490,197.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ7.03 B-376,638.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ26.89 B-1,440,405.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚ฌ1.18 B-63,774.22%๐Ÿ‡บ๐Ÿ‡ธ USA